This single institution study evalated the effect of prosthesis choice on regression of LV mass after AVR in patients with AS. The St.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic valve disease
October 31, 2016
October 31, 2016
This single institution retrospective study evaluated outcomes of valve replacement for degenerated bioprosthetic aortic valves comparing surgical AVR (SAVR) to transcatheter valve-in-valve procedures (TViV). Patients were matched into 2 groups of 22 according to STS risk scores. Operative mortality, stroke rate, and 3-year survival were similar b
October 13, 2016
This is the first report of the use of a balloon expandable transcatheter heart valve (Edwards Sapiens 3) for TAVI in chronic aortic regurgitation (AR) involving non-calcified native valves. The authors implanted Edwards Sapiens 3 prostheses in three patients with severe AR deemed inoperable by the heart team.
October 13, 2016
This single center retrospective study analyzed the incidence of permanent pacemaker requirement in 108 consecutive patients undergoing sutureless aortic valve replacement with the Perceval S bioprosthesis.
September 27, 2016
This analysis of PARTNER data evaluated the impact of chronic kidney disease (CKD) on outcomes after TAVR. Patients were grouped according to GFR as none/mild, moderate, and severe renal disease. Severe disease was most common among women with diabetes.
September 27, 2016
This single institution retrospective review assessed outcomes of AVR in patients with concomitant aortic root disease using a composite graft. Early mortality was 5.3% and was related to advanced age, poor NYHA status, urgent operation, and associated MVR or CABG.
September 27, 2016
The authors demonstrate how to perform mitroaortic replacement using the David Technique in a case of prosthethic endocarditis.
September 21, 2016
This clinical case describes a double valve surgery in a 58-year-old female patient with Scheie's syndrome, and considers treatment options for symptoms of this rare condition.
September 12, 2016
The presence of a bicuspid valve has been considered as a relative contraindication for transcatheter aortic valve implantation (TAVI). This a multicentre retrospective study of 51 patients with bicuspid aortic stenosis who had undergone TAVI using a next-generation transcatheter heart valve (Edwards SAPIEN 3). 30- day mortality was 3,9%.
September 7, 2016
This multistudy registry, entitled ROUTE, studied the effectiveness and safety of transaortic access for TAVI in 301 patients. Mean age was 82 years and mean STS Score 9.0. Valve success was 97%.